PI3K/mTOR-IN-17

Product Specifications

Target

PI3K|||Apoptosis|||Caspase|||Bcl-2 Family|||MDM-2/p53|||mTOR

Related Pathways

Apoptosis|||PI3K/Akt/mTOR signaling|||Proteases/Proteasome

Bioactivity

PI3K/mTOR-IN-17 is a dual inhibitor that targets both PI3K and mTOR, with IC50 values of 1.21 ?M and 0.21 ?M, respectively. It induces apoptosis mediated by caspases and arrests cell growth in the G1 phase. The compound elevates the levels of caspases-3, 7, 8, and 9, enhances p53 expression, and increases the Bax/Bcl-2 ratio. By inhibiting the PI3K/mTOR signaling pathway, PI3K/mTOR-IN-17 is applicable in cancer research, including studies on non-small cell lung cancer (NSCLC) .